Pre-clinical study of amcenestrant and HER2-targeted therapies in HER2+/ER+ breast cancer cell line models

Mahdi, AF; Ashfield, N; Conlon, NT; Crown, J; Collins, DM

CANCER RESEARCH, 2023; 83 (5):